Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BowTiedBiotech Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1462941795520638981.png) BowTiedBiotech 🧪🔬🧬 [@BowTiedBiotech](/creator/twitter/BowTiedBiotech) on x 19.6K followers
Created: 2025-07-09 11:02:31 UTC

5/ Hidden Insight: This Isn’t Just About COPD

Ohtuvayre is approved for COPD maintenance therapy, but Merck’s language hints at broader ambitions.

What to potentially watch:
🔹Asthma
🔹Bronchiectasis
🔹Long-COVID

💡Prediction: This becomes a pipeline-in-a-drug with label expansion trials starting in 2026.

![](https://pbs.twimg.com/media/GvaS__yXIAAs2rK.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942902180912013324/c:line.svg)

**Related Topics**
[prediction](/topic/prediction)
[approved](/topic/approved)

[Post Link](https://x.com/BowTiedBiotech/status/1942902180912013324)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BowTiedBiotech Avatar BowTiedBiotech 🧪🔬🧬 @BowTiedBiotech on x 19.6K followers Created: 2025-07-09 11:02:31 UTC

5/ Hidden Insight: This Isn’t Just About COPD

Ohtuvayre is approved for COPD maintenance therapy, but Merck’s language hints at broader ambitions.

What to potentially watch: 🔹Asthma 🔹Bronchiectasis 🔹Long-COVID

💡Prediction: This becomes a pipeline-in-a-drug with label expansion trials starting in 2026.

XXXXX engagements

Engagements Line Chart

Related Topics prediction approved

Post Link

post/tweet::1942902180912013324
/post/tweet::1942902180912013324